Day: June 27, 2024

DENVER, June 27, 2024 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen and thirty-nine weeks ended May 25, 2024. The Company completed the acquisition of Only What You Need, Inc. (“OWYN”) on June 13, 2024, therefore, fiscal third quarter 2024 results exclude the performance of this brand. The reference to “legacy” Simply Good Foods in this press release encompasses Simply Good Foods’ business excluding OWYN. Third Quarter Summary:(1)Net sales of $334.8 million versus $324.8 million Net income of $41.3 million versus $35.4 million Earnings per diluted share (“EPS”) of $0.41 versus $0.35 Adjusted Diluted EPS(2)...

Tier-1 Customer to Use Akoustis’ Next-Generation 5.5 and 6.5 GHz Wi-Fi XBAW® Filters in Tri-Band 4×4 MIMO Router Secured Wi-Fi 7 Filter Orders to Support Production Beginning in July 2024 Through March 2025  Charlotte, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that the company has received $2M in production orders from Tier-1 carrier customer to satisfy demand for two of its industry-leading XBAW® filters integrated into a Wi-Fi 7 platform. Wi-Fi technology continues to advance to enable higher data transfer rates and greater density per transmission. With the integration of multiple Akoustis XBAW®...

DURHAM, N.C., June 27, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the launch of its artificial intelligence (AI) Innovation Studio, signaling a strategic investment in reshaping the execution of clinical trials today and into the future. The studio will develop and deploy AI and machine learning (ML) technologies to drive speed, agility, quality and enhanced patient safety in the clinical research process by equipping and empowering people to focus on the critical human element of clinical trials. “Patients around the world are waiting for novel, life-changing treatments. With AI, we now have the power—and the obligation—to help deliver solutions to them faster,” said Fortrea’s Chief Information Officer Alejandro Martinez Galindo. “Fortrea’s AI Innovation...

Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using a 21/7 schedule; currently assessing 0.75 mg dose level; final determination of recommended Phase 2 dose and updated clinical results anticipated in H2 2024 IND submission achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; initiation of Phase 1 SAD/MAD study expected this summer with Phase 1 clinical data anticipated in Q1 2025 BOSTON, June 27, 2024 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced progress updates for its two lead programs, MRT-2359, an MGD being developed for MYC-driven solid tumors,...

LAS VEGAS, June 27, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence (“AI”) company, today announced the commencement of an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding (i) redeemable warrants to purchase shares of Company common stock, par value $0.0001 per share (the “common stock”), which warrants trade on The Nasdaq Capital Market under the symbol “JTAIW” (the “redeemable warrants”), (ii) merger consideration warrants to purchase shares of common stock, which warrants trade on the Nasdaq Capital Market under the symbol “JTAIZ” (the “merger consideration warrants”), and (iii) private placement warrants to purchase shares of common stock (the “private placement warrants” and,...

Today’s Broadcast “This Week in Jacksonville Business Edition” Host Kent Justice talks with CEO Chuck Ferry and Duos Edge AI President Doug Recker on the Company’s recent entry into the data center market and a strategic partnership in rail JACKSONVILLE, Fla., June 27, 2024 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), CEO Chuck Ferry and newly appointed President of Duos Edge AI, Doug Recker, are being featured on “This Week in Jacksonville – Business Edition”, broadcasting today at 9am EDT. They will discuss Duos’ recent business expansion and expected contributions to economic growth and development in the Jacksonville area and beyond. The interview is available for viewing at    https://www.news4jax.com/topic/Business_Edition/.The interview is expected to provide a...

Canoo’s Lifestyle Delivery Vehicle 190 (LDV 190) won the Best of the Best in the Commercial Vehicles Category Canoo’s LDV 190 is also nominated for the Red Dot: Luminary, the highest recognition accorded at the Red Dot Award: Design Concept Canoo’s American Bulldog electric pickup truck is recognized as a 2024 Red Dot winner Canoo’s first commercial customer of the LDV 190 is the United States Postal Service (USPS)JUSTIN, Texas, June 27, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (Nasdaq: GOEV), a high-tech advanced mobility company, today announced that the company has been honored by receiving several Red Dot Design Awards, including the coveted “Best of the Best” award, which is awarded to pioneering designs, in the Red Dot: Design Concept 2024 for its Lifestyle Delivery Vehicle 190 (LDV 190). Canoo received a nomination for...

VANCOUVER, British Columbia, June 27, 2024 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | Nasdaq:AMLI | Frankfurt:5LA1) is pleased to provide an update on the optimization of the Falchani processing flow-sheet. This update is based on recently completed, and ongoing, test work at Australian Nuclear Science and Technology Organization Laboratories in Sydney, Australia (“ANSTO”) in conjunction with TECMMINE in Lima, Peru (“TECMMINE”). The unique volcanic style of lithium mineralization at Falchani, combined with low impurity content allows its flow-sheet to resemble more conventional mining / processing flow-sheets versus most hardrock lithium projects where concentrates are produced and then shipped elsewhere for further refining into higher quality products. Falchani’s flow-sheet utilizes...

JERICHO, N.Y., June 27, 2024 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-used properties in the United States, has published its 2023 Corporate Responsibility Report. The report highlights the company’s progress in addressing environmental, social, and governance (ESG) topics, which have been an area of focus for Kimco and its stakeholders for over a decade. “We take great pride in the tangible progress Kimco has made in 2023, demonstrating our commitment to our stakeholders through both actions and results,” said Kimco CEO Conor Flynn. “Our achievements reflect a shared vision that intertwines financial performance with corporate responsibility and sustainability excellence.” Kimco...

Event scheduled for Wednesday, July 24, 2024, at 8:00 am EDT FLORHAM PARK, N.J., June 27, 2024 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host an event on July 24, 2024, at 8:00 a.m., EDT, to provide a comprehensive overview of recent data from its pivotal trial of iopofosine I 131 in Waldenstrom’s macroglobulinemia, the current treatment landscape, unmet needs for patients with this disease, and opportunities to improve patient outcomes. The event will feature both company leadership and key investigators, who will discuss the CLOVER WaM study (NCT02952508) and full results. Details are as follows: Conference Call DetailsDate: July 24, 2024Time:...